• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical study.在存在终末事件的情况下,从比较临床研究中量化多个事件时间观察的治疗效果总和。
Stat Med. 2018 Nov 10;37(25):3589-3598. doi: 10.1002/sim.7907. Epub 2018 Jul 25.
2
Estimation on conditional restricted mean survival time with counting process.用计数过程估计条件受限平均生存时间。
J Biopharm Stat. 2021 Mar;31(2):141-155. doi: 10.1080/10543406.2020.1814799. Epub 2020 Sep 6.
3
A systematic comparison of recurrent event models for application to composite endpoints.系统比较应用于复合终点的复发事件模型。
BMC Med Res Methodol. 2018 Jan 4;18(1):2. doi: 10.1186/s12874-017-0462-x.
4
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.利用两个生存函数的综合差异来量化治疗对比,以用于设计、监测和分析比较性临床研究。
Clin Trials. 2012 Oct;9(5):570-7. doi: 10.1177/1740774512455464. Epub 2012 Aug 22.
5
Use of the Wei-Lin-Weissfeld method for the analysis of a recurring and a terminating event.使用魏-林-魏斯费尔德方法分析复发事件和终止事件。
Stat Med. 1997 Apr 30;16(8):925-40. doi: 10.1002/(sici)1097-0258(19970430)16:8<925::aid-sim545>3.0.co;2-2.
6
Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.心脏病学试验中相互竞争的事件发生时间终点:一项模拟研究以说明充分统计分析的重要性。
Eur J Prev Cardiol. 2014 Jan;21(1):74-80. doi: 10.1177/2047487312460518. Epub 2012 Sep 10.
7
Analysis of a composite endpoint with longitudinal and time-to-event data.对具有纵向和生存数据的复合终点进行分析。
Stat Med. 2011 Apr 30;30(9):1018-27. doi: 10.1002/sim.4199. Epub 2011 Feb 22.
8
Semiparametric methods for multistate survival models in randomised trials.随机试验中多状态生存模型的半参数方法。
Stat Med. 2014 May 10;33(10):1621-45. doi: 10.1002/sim.6060. Epub 2013 Dec 13.
9
A DAG-based comparison of interventional effect underestimation between composite endpoint and multi-state analysis in cardiovascular trials.基于有向无环图的心血管试验中复合终点与多状态分析之间干预效果低估的比较。
BMC Med Res Methodol. 2017 Jul 4;17(1):92. doi: 10.1186/s12874-017-0366-9.
10
Semiparametric transformation models with random effects for joint analysis of recurrent and terminal events.用于复发事件和终末事件联合分析的具有随机效应的半参数转换模型
Biometrics. 2009 Sep;65(3):746-52. doi: 10.1111/j.1541-0420.2008.01126.x. Epub 2008 Sep 29.

引用本文的文献

1
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial.替格瑞洛联合或不联合阿司匹林对经皮冠状动脉介入治疗后总出血及再发出血和缺血事件的影响:TWILIGHT试验的一项子研究
Eur Heart J Cardiovasc Pharmacother. 2025 Feb 8;11(1):66-74. doi: 10.1093/ehjcvp/pvae080.
2
Validating new symptom emergence as a patient-centric outcome measure for PD clinical trials.验证新症状出现作为 PD 临床试验的以患者为中心的结局指标。
Parkinsonism Relat Disord. 2024 Nov;128:107118. doi: 10.1016/j.parkreldis.2024.107118. Epub 2024 Sep 10.
3
Quantifying Treatment Effects in Trials with Multiple Event-Time Outcomes.在具有多个事件时间结局的试验中量化治疗效果
NEJM Evid. 2022 Oct;1(10). doi: 10.1056/evidoa2200047. Epub 2022 Jun 30.
4
Causal inference with recurrent and competing events.具有复发和竞争事件的因果推断。
Lifetime Data Anal. 2024 Jan;30(1):59-118. doi: 10.1007/s10985-023-09594-8. Epub 2023 May 12.
5
Nonparametric inference of general while-alive estimands for recurrent events.非参数推断在重复事件中一般存活估计量。
Biometrics. 2023 Sep;79(3):1749-1760. doi: 10.1111/biom.13709. Epub 2022 Jul 22.
6
Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies.在比较性临床研究中选择具有临床可解释性的汇总指标和稳健的分析程序以量化治疗差异。
Stat Med. 2021 Dec 10;40(28):6235-6242. doi: 10.1002/sim.8971.
7
Statistical models for composite endpoints of death and non-fatal events: a review.死亡和非致命事件复合终点的统计模型:综述
Stat Biopharm Res. 2021;13(3):260-269. doi: 10.1080/19466315.2021.1927824. Epub 2021 Jul 6.

本文引用的文献

1
Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?受限平均生存时间:癌症试验中事件发生时间分析的必要终点?
J Clin Oncol. 2016 Oct 1;34(28):3474-6. doi: 10.1200/JCO.2016.67.8045. Epub 2016 Aug 9.
2
Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials.肿瘤学随机对照试验中风险比和受限平均生存时间比测量的治疗效果比较。
J Clin Oncol. 2016 May 20;34(15):1813-9. doi: 10.1200/JCO.2015.64.2488. Epub 2016 Feb 16.
3
Semiparametric regression for the weighted composite endpoint of recurrent and terminal events.针对复发和终末事件加权复合终点的半参数回归
Biostatistics. 2016 Apr;17(2):390-403. doi: 10.1093/biostatistics/kxv050. Epub 2015 Dec 14.
4
Statistical inference methods for recurrent event processes with shape and size parameters.具有形状和大小参数的复发事件过程的统计推断方法。
Biometrika. 2014 Sep 1;101(3):553-566. doi: 10.1093/biomet/asu016.
5
Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies.非劣效性研究中用于比较治疗效果或安全性的风险比替代方法。
Ann Intern Med. 2015 Jul 21;163(2):127-34. doi: 10.7326/M14-1741.
6
Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis.超越风险比:在生存分析中量化组间差异。
J Clin Oncol. 2014 Aug 1;32(22):2380-5. doi: 10.1200/JCO.2014.55.2208. Epub 2014 Jun 30.
7
Predicting the restricted mean event time with the subject's baseline covariates in survival analysis.在生存分析中利用受试者的基线协变量预测受限平均事件时间。
Biostatistics. 2014 Apr;15(2):222-33. doi: 10.1093/biostatistics/kxt050. Epub 2013 Nov 29.
8
Analyzing Recurrent Event Data With Informative Censoring.使用信息性删失分析复发事件数据。
J Am Stat Assoc. 2001;96(455). doi: 10.1198/016214501753209031.
9
Joint Modeling and Estimation for Recurrent Event Processes and Failure Time Data.复发事件过程与失效时间数据的联合建模与估计
J Am Stat Assoc. 2004 Dec;99(468):1153-1165. doi: 10.1198/016214504000001033.
10
Calibrating parametric subject-specific risk estimation.校准参数化的个体特异性风险估计。
Biometrika. 2010 Jun;97(2):389-404. doi: 10.1093/biomet/asq012.

在存在终末事件的情况下,从比较临床研究中量化多个事件时间观察的治疗效果总和。

Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical study.

机构信息

Harvard Medical School, Boston, Massachusetts.

Stanford University School of Medicine, Stanford, California.

出版信息

Stat Med. 2018 Nov 10;37(25):3589-3598. doi: 10.1002/sim.7907. Epub 2018 Jul 25.

DOI:10.1002/sim.7907
PMID:30047148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7021204/
Abstract

To evaluate the totality of one treatment's benefit/risk profile relative to an alternative treatment via a longitudinal comparative clinical study, the timing and occurrence of multiple clinical events are typically collected during the patient's follow-up. These multiple observations reflect the patient's disease progression/burden over time. The standard practice is to create a composite endpoint from the multiple outcomes, the timing of the occurrence of the first clinical event, to evaluate the treatment via the standard survival analysis techniques. By ignoring all events after the composite outcome, this type of assessment may not be ideal. Various parametric or semiparametric procedures have been extensively discussed in the literature for the purposes of analyzing multiple event-time data. Many existing methods were developed based on extensive model assumptions. When the model assumptions are not plausible, the resulting inferences for the treatment effect may be misleading. In this article, we propose a simple, nonparametric inference procedure to quantify the treatment effect, which has an intuitive clinically meaningful interpretation. We use the data from a cardiovascular clinical trial for heart failure to illustrate the procedure. A simulation study is also conducted to evaluate the performance of the new proposal.

摘要

为了通过纵向比较临床研究评估一种治疗方法相对于另一种治疗方法的总体获益/风险情况,通常会在患者随访期间收集多个临床事件的时间和发生情况。这些多次观察反映了患者随时间推移的疾病进展/负担。标准做法是从多个结局中创建一个复合终点,即第一个临床事件发生的时间,然后通过标准生存分析技术评估治疗效果。通过忽略复合终点之后的所有事件,这种评估可能并不理想。文献中广泛讨论了各种参数或半参数程序,以分析多次事件时间数据。许多现有的方法都是基于广泛的模型假设而开发的。当模型假设不可信时,对治疗效果的推断可能会产生误导。在本文中,我们提出了一种简单的、非参数推断程序来量化治疗效果,这种方法具有直观的临床意义解释。我们使用心力衰竭的心血管临床试验数据来说明该程序。还进行了一项模拟研究来评估新提案的性能。